ARTIVION INC (AORT) Fundamental Analysis & Valuation

NYSE:AORT • US2289031005

35.96 USD
-0.13 (-0.36%)
At close: Mar 10, 2026
35.96 USD
0 (0%)
After Hours: 3/10/2026, 7:00:47 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This AORT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Taking everything into account, AORT scores 5 out of 10 in our fundamental rating. AORT was compared to 184 industry peers in the Health Care Equipment & Supplies industry. AORT has only an average score on both its financial health and profitability. AORT is growing strongly while it is still valued neutral. This is a good combination! These ratings could make AORT a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

5

1. AORT Profitability Analysis

1.1 Basic Checks

  • In the past year AORT was profitable.
  • AORT had a positive operating cash flow in the past year.
  • In the past 5 years AORT reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: AORT reported negative operating cash flow in multiple years.
AORT Yearly Net Income VS EBIT VS OCF VS FCFAORT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.10%, AORT is in the better half of the industry, outperforming 72.83% of the companies in the same industry.
  • The Return On Equity of AORT (2.18%) is better than 73.37% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.26%, AORT is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for AORT is significantly below the industry average of 9.15%.
Industry RankSector Rank
ROA 1.1%
ROE 2.18%
ROIC 2.26%
ROA(3y)-1.48%
ROA(5y)-1.76%
ROE(3y)-4.5%
ROE(5y)-5.02%
ROIC(3y)2.51%
ROIC(5y)N/A
AORT Yearly ROA, ROE, ROICAORT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10

1.3 Margins

  • The Profit Margin of AORT (2.21%) is better than 73.91% of its industry peers.
  • AORT has a better Operating Margin (6.06%) than 71.20% of its industry peers.
  • AORT's Operating Margin has improved in the last couple of years.
  • AORT's Gross Margin of 64.40% is fine compared to the rest of the industry. AORT outperforms 69.02% of its industry peers.
  • AORT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.06%
PM (TTM) 2.21%
GM 64.4%
OM growth 3YN/A
OM growth 5Y12.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.57%
AORT Yearly Profit, Operating, Gross MarginsAORT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. AORT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AORT is destroying value.
  • The number of shares outstanding for AORT has been increased compared to 1 year ago.
  • Compared to 5 years ago, AORT has more shares outstanding
  • The debt/assets ratio for AORT has been reduced compared to a year ago.
AORT Yearly Shares OutstandingAORT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
AORT Yearly Total Debt VS Total AssetsAORT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • AORT has an Altman-Z score of 3.24. This indicates that AORT is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of AORT (3.24) is better than 70.65% of its industry peers.
  • The Debt to FCF ratio of AORT is 260.47, which is on the high side as it means it would take AORT, 260.47 years of fcf income to pay off all of its debts.
  • AORT has a better Debt to FCF ratio (260.47) than 67.39% of its industry peers.
  • AORT has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
  • AORT has a Debt to Equity ratio of 0.49. This is comparable to the rest of the industry: AORT outperforms 41.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 260.47
Altman-Z 3.24
ROIC/WACC0.23
WACC9.99%
AORT Yearly LT Debt VS Equity VS FCFAORT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 3.53 indicates that AORT has no problem at all paying its short term obligations.
  • AORT has a better Current ratio (3.53) than 60.87% of its industry peers.
  • A Quick Ratio of 2.62 indicates that AORT has no problem at all paying its short term obligations.
  • AORT has a better Quick ratio (2.62) than 60.33% of its industry peers.
Industry RankSector Rank
Current Ratio 3.53
Quick Ratio 2.62
AORT Yearly Current Assets VS Current LiabilitesAORT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. AORT Growth Analysis

3.1 Past

  • AORT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 141.86%, which is quite impressive.
  • AORT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.78% yearly.
  • Looking at the last year, AORT shows a quite strong growth in Revenue. The Revenue has grown by 13.59% in the last year.
  • The Revenue has been growing by 11.75% on average over the past years. This is quite good.
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y12.04%
Revenue growth 5Y11.75%
Sales Q2Q%19.2%

3.2 Future

  • Based on estimates for the next years, AORT will show a very strong growth in Earnings Per Share. The EPS will grow by 70.33% on average per year.
  • The Revenue is expected to grow by 12.25% on average over the next years. This is quite good.
EPS Next Y102.54%
EPS Next 2Y107.21%
EPS Next 3Y69.87%
EPS Next 5Y70.33%
Revenue Next Year11.86%
Revenue Next 2Y11.51%
Revenue Next 3Y11.73%
Revenue Next 5Y12.25%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
AORT Yearly Revenue VS EstimatesAORT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
AORT Yearly EPS VS EstimatesAORT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. AORT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 199.78 indicates a quite expensive valuation of AORT.
  • Based on the Price/Earnings ratio, AORT is valued a bit cheaper than the industry average as 63.59% of the companies are valued more expensively.
  • AORT is valuated expensively when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 98.63, the valuation of AORT can be described as expensive.
  • Based on the Price/Forward Earnings ratio, AORT is valued a bit cheaper than 65.76% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of AORT to the average of the S&P500 Index (24.39), we can say AORT is valued expensively.
Industry RankSector Rank
PE 199.78
Fwd PE 98.63
AORT Price Earnings VS Forward Price EarningsAORT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • 66.85% of the companies in the same industry are more expensive than AORT, based on the Enterprise Value to EBITDA ratio.
  • AORT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AORT is cheaper than 67.39% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2052.16
EV/EBITDA 38.24
AORT Per share dataAORT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AORT does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as AORT's earnings are expected to grow with 69.87% in the coming years.
PEG (NY)1.95
PEG (5Y)N/A
EPS Next 2Y107.21%
EPS Next 3Y69.87%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AORT Dividend Analysis

5.1 Amount

  • AORT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AORT Fundamentals: All Metrics, Ratios and Statistics

ARTIVION INC

NYSE:AORT (3/10/2026, 7:00:47 PM)

After market: 35.96 0 (0%)

35.96

-0.13 (-0.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)05-04
Inst Owners88.38%
Inst Owner ChangeN/A
Ins Owners4.23%
Ins Owner Change5.62%
Market Cap1.72B
Revenue(TTM)441.33M
Net Income(TTM)9.76M
Analysts83.08
Price Target52.46 (45.88%)
Short Float %3.2%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)101.61%
Min EPS beat(2)-39.98%
Max EPS beat(2)243.19%
EPS beat(4)3
Avg EPS beat(4)555.79%
Min EPS beat(4)-39.98%
Max EPS beat(4)1928.24%
EPS beat(8)5
Avg EPS beat(8)220.91%
EPS beat(12)7
Avg EPS beat(12)112.9%
EPS beat(16)11
Avg EPS beat(16)108.2%
Revenue beat(2)0
Avg Revenue beat(2)-1.72%
Min Revenue beat(2)-2.32%
Max Revenue beat(2)-1.12%
Revenue beat(4)2
Avg Revenue beat(4)0.33%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)2.59%
Revenue beat(8)3
Avg Revenue beat(8)-0.34%
Revenue beat(12)7
Avg Revenue beat(12)0.64%
Revenue beat(16)9
Avg Revenue beat(16)0.45%
PT rev (1m)-0.55%
PT rev (3m)-0.55%
EPS NQ rev (1m)-31.99%
EPS NQ rev (3m)-31.99%
EPS NY rev (1m)-19.32%
EPS NY rev (3m)-20.77%
Revenue NQ rev (1m)2.61%
Revenue NQ rev (3m)2.61%
Revenue NY rev (1m)0.81%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE 199.78
Fwd PE 98.63
P/S 3.9
P/FCF 2052.16
P/OCF 43.17
P/B 3.84
P/tB 45.74
EV/EBITDA 38.24
EPS(TTM)0.18
EY0.5%
EPS(NY)0.36
Fwd EY1.01%
FCF(TTM)0.02
FCFY0.05%
OCF(TTM)0.83
OCFY2.32%
SpS9.22
BVpS9.36
TBVpS0.79
PEG (NY)1.95
PEG (5Y)N/A
Graham Number6.16
Profitability
Industry RankSector Rank
ROA 1.1%
ROE 2.18%
ROCE 3.41%
ROIC 2.26%
ROICexc 2.46%
ROICexgc 5.74%
OM 6.06%
PM (TTM) 2.21%
GM 64.4%
FCFM 0.19%
ROA(3y)-1.48%
ROA(5y)-1.76%
ROE(3y)-4.5%
ROE(5y)-5.02%
ROIC(3y)2.51%
ROIC(5y)N/A
ROICexc(3y)2.72%
ROICexc(5y)N/A
ROICexgc(3y)6.7%
ROICexgc(5y)N/A
ROCE(3y)3.8%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y12.65%
ROICexc growth 3YN/A
ROICexc growth 5Y23.53%
OM growth 3YN/A
OM growth 5Y12.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.07%
GM growth 5Y-0.57%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.49
Debt/FCF 260.47
Debt/EBITDA 4.43
Cap/Depr 173.84%
Cap/Sales 8.85%
Interest Coverage 0.95
Cash Conversion 81.05%
Profit Quality 8.6%
Current Ratio 3.53
Quick Ratio 2.62
Altman-Z 3.24
F-Score7
WACC9.99%
ROIC/WACC0.23
Cap/Depr(3y)84.09%
Cap/Depr(5y)70.92%
Cap/Sales(3y)4.61%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.86%
EPS 3YN/A
EPS 5Y-4.78%
EPS Q2Q%112.82%
EPS Next Y102.54%
EPS Next 2Y107.21%
EPS Next 3Y69.87%
EPS Next 5Y70.33%
Revenue 1Y (TTM)13.59%
Revenue growth 3Y12.04%
Revenue growth 5Y11.75%
Sales Q2Q%19.2%
Revenue Next Year11.86%
Revenue Next 2Y11.51%
Revenue Next 3Y11.73%
Revenue Next 5Y12.25%
EBIT growth 1Y-0.48%
EBIT growth 3YN/A
EBIT growth 5Y25.35%
EBIT Next Year219.45%
EBIT Next 3Y66.04%
EBIT Next 5Y45.21%
FCF growth 1Y-92.41%
FCF growth 3YN/A
FCF growth 5Y-30.14%
OCF growth 1Y79.35%
OCF growth 3YN/A
OCF growth 5Y26.38%

ARTIVION INC / AORT FAQ

Can you provide the ChartMill fundamental rating for ARTIVION INC?

ChartMill assigns a fundamental rating of 5 / 10 to AORT.


What is the valuation status of ARTIVION INC (AORT) stock?

ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.


Can you provide the profitability details for ARTIVION INC?

ARTIVION INC (AORT) has a profitability rating of 5 / 10.


What are the PE and PB ratios of ARTIVION INC (AORT) stock?

The Price/Earnings (PE) ratio for ARTIVION INC (AORT) is 199.78 and the Price/Book (PB) ratio is 3.84.